ASX 200 Dips as Amplia Therapeutics and LI-S Energy Outperform in Mixed Market Start

May 15, 2025 08:00 AM BST | By Team Kalkine Media
 ASX 200 Dips as Amplia Therapeutics and LI-S Energy Outperform in Mixed Market Start
Image source: Shutterstock

Highlights

  • Amplia Therapeutics (ASX:ATX) surges following positive pancreatic cancer trial update

  • LI-S Energy (ASX:LIS) gains with progress on drone battery platform and lithium foil project

  • ASX 200 opens lower amid broad sector losses and weaker commodity prices

The ASX 200 opened the session on a softer note, showing a modest retreat in early trade. The index was weighed down by a decline in the materials sector, coupled with weakness in global commodities including oil, gold, and iron ore. Among the top sectoral performers, consumer discretionary provided some resilience, while financials also displayed selective gains.

International Market Conditions Mixed

Overseas markets reflected a pause in recent rallies. The Nasdaq rose slightly, supported by gains in key technology names. Nvidia advanced on the back of a new agreement with a Middle Eastern data center operator, while AMD also gained after initiating a sizeable share repurchase plan. Super Micro Computer climbed significantly following a new contract with a Gulf-based infrastructure group.

The Dow Jones edged down while the S&P500 managed a fractional uptick. In Europe, banks led the market upward, yet losses in healthcare names dragged indices lower, with the FTSE100 and FTSE300 recording small dips.

Amplia Therapeutics (ASX:ATX) Leads Market Gains

Amplia Therapeutics (ASX:ATX) emerged among the session's strongest performers. The biotech firm announced updated results from its ACCENT clinical trial, evaluating its lead candidate narmafotinib in combination with chemotherapeutic agents gemcitabine and Abraxane. The treatment showed encouraging signs, with several patients experiencing measurable tumour reductions and no progression observed in recent assessments. The news lifted confidence in the company's approach to pancreatic cancer research.

LI-S Energy (ASX:LIS) Advances on Technology Development

Battery innovator LI-S Energy (ASX:LIS) also recorded notable gains. The company announced ground testing for its Pegasus I platform, which is aimed at enabling continuous drone flight from sunrise to sunset. A recent flight test using a lithium-sulphur battery-powered drone delivered promising results. Additionally, LI-S Energy highlighted the ongoing construction of a lithium foil production line supported by national funding, reinforcing its role in battery innovation.

Financial Stocks Edge Up in Mixed Session

While the broader market moved lower, select financial names posted gains. Commonwealth Bank (ASX:CBA) and National Australia Bank (ASX:NAB) recorded early increases. Insurance Australia Group (ASX:IAG) also moved higher, standing out among peers.

Other Notable Winners

Among the smaller-cap names, Anagenics Limited (ASX:AN1), Black Canyon Limited (ASX:BCA), and EDU Holdings Limited (ASX:EDU) all registered increases. Energy Resources of Australia (ASX:ERA) and South Harz Potash (ASX:SHP) were also up during early trade.

Key Decliners in Early Trade

On the downside, Avecho Biotech Ltd (ASX:AVE), Biotron Limited (ASX:BIT), and Seafarms Group Ltd (ASX:SFG) were among the laggards, with several trading at lower volumes. Citigold Corp Ltd (ASX:CTO), Terrain Minerals (ASX:TMX), and Jayride Group (ASX:JAY) also recorded declines. The pullback came amid investor caution and lower commodity prices impacting sentiment in resource-focused stocks.

Sectoral Performance Reflects Market Sentiment

The materials sector led losses as commodity-linked names faced selling pressure. Eight of eleven sectors were trading in the red, underscoring broad caution. Despite this, the consumer discretionary sector moved higher, reflecting selective buying in retail and lifestyle segments.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next